Pharming Group Engages Investors with Upcoming Conferences
Pharming Group to Participate in Major Investor Conferences
Leiden, Netherlands: Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is excited to announce its participation in several key investor conferences scheduled for April. The management team is eager to connect with investors and present the company’s strategic initiatives and innovative product pipeline.
Upcoming Conferences
Pharming will take part in the following prestigious conferences this coming month:
Van Lanschot Kempen Life Sciences Conference 2025
Set to occur on April 2-3, this conference will bring together leaders and innovators from the life sciences sector in Amsterdam. Pharming’s representation at this event underscores its commitment to staying at the forefront of biopharmaceutical advancements.
24th Annual Needham Virtual Healthcare Conference
Scheduled for April 7-10, the Needham conference is a vital platform for engaging with investors interested in the healthcare industry. Pharming's CEO, Fabrice Chouraqui, along with CMO Anurag Relan, will provide a detailed presentation on April 8 at 10:15 AM ET (16:15 CET). A live webcast of their presentation will be accessible through the company’s website in the “Upcoming Events” section.
Investor Relations Engagement
Pharming encourages interested investors to reach out for further information about these conferences or to arrange one-on-one meetings with its management team. The Investor Relations team can be contacted directly via email.
About Pharming Group N.V.
Pharming Group N.V. is a leading global biopharmaceutical company focused on transforming the lives of patients suffering from rare and debilitating diseases. With a diverse portfolio including both small molecules and biologics, Pharming is committed to developing and commercializing innovative therapies. The company’s headquarters are situated in Leiden, the Netherlands, with a dedicated workforce serving patients across North America, Europe, the Middle East, Africa, and Asia-Pacific.
For additional details, please visit Pharming’s official website and follow them on LinkedIn for the latest updates.
Contact Information
If you seek further information, please contact the Pharming team directly:
Pharming Group, Leiden, the Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: investor@pharming.com
FTI Consulting, London, United Kingdom
Simon Conway/Alex Shaw/Amy Byrne
T: +44 203 727 1000
LifeSpring Life Sciences Communication, Amsterdam, the Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl
Frequently Asked Questions
What conferences will Pharming attend in April?
Pharming will participate in the Van Lanschot Kempen Life Sciences Conference and the 24th Annual Needham Virtual Healthcare Conference.
Who will represent Pharming at these conferences?
CEO Fabrice Chouraqui and CMO Anurag Relan will be presenting at the Needham Virtual Healthcare Conference.
How can investors get more information?
Investors can contact Pharming’s Investor Relations team via email for more information or to schedule meetings.
What is Pharming's primary focus?
Pharming is dedicated to developing therapies for patients with rare and life-threatening diseases, focusing on innovative biopharmaceutical solutions.
Where is Pharming headquartered?
Pharming Group N.V. is headquartered in Leiden, the Netherlands.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.